MedPath

Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with Influenza

Not yet recruiting
Conditions
Influenza
Registration Number
jRCT1051180014
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

1)axillary temperature more than 37.5 degree
2)a positive rapid antigen test for influenza virus
3)a symptom duraiton of no more than 36 hours
4)hospitalized patient
5)body weight more than 10kg

Exclusion Criteria

1)patients who have suffered from bacterial infection or other viral infection within one week from the start of the study
2)patients who received recipes of Baloxavir marboxil, Oseltamivir, Zanavivir, Laninavir, Peramivir within 4 weeks from the start of the study

Study & Design

Study Type
Interventional
Study Design
single assignment
Primary Outcome Measures
NameTimeMethod
-

The time to alleviation of influenza symptoms

The time to resolution of fever

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.